ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
-0,49%
Bitcoin
66.217,37
0,32%
Brent Oil
82,275
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Idera Pharmaceuticals (IDP)

  7. Idera Pharmaceuticals (IDP) Notícias

IDP

Idera Pharmaceutical (IDP)

Idera Pharmaceuticals
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:IDP
DataHoraFonteTítuloCódigoCompanhia
26/11/200716:10Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:IDPIdera Pharmaceuticals
21/11/200720:52Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:IDPIdera Pharmaceuticals
16/11/200719:31Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Securities Registration: Employee Benefit Plan (S-8)AMEX:IDPIdera Pharmaceuticals
13/11/200711:15Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (10-Q)AMEX:IDPIdera Pharmaceuticals
09/11/200712:33Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Statement of Ownership (SC 13G)AMEX:IDPIdera Pharmaceuticals
27/09/200715:42Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (4)AMEX:IDPIdera Pharmaceuticals
27/09/200715:39Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (3)AMEX:IDPIdera Pharmaceuticals
27/09/200709:24Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (8-K)AMEX:IDPIdera Pharmaceuticals
14/08/200709:00Business WireIdera Pharmaceuticals Announces Publication of Preclinical Data on Toll-Like Receptor 7 and 8 AgonistsAMEX:IDPIdera Pharmaceuticals
03/08/200709:00Business WireIdera Pharmaceuticals to Present at Canaccord Adams 27th Annual Global Growth ConferenceAMEX:IDPIdera Pharmaceuticals
01/08/200709:30Business WireIdera Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2007AMEX:IDPIdera Pharmaceuticals
17/07/200710:23Business WireIdera Pharmaceuticals Announces Publication of Study of Toll-Like Receptor 9 Agonist in Combination with Avastin(R) in PreclinicAMEX:IDPIdera Pharmaceuticals
17/07/200709:00Business WireIdera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Rheumatoid Arthritis ModelsAMEX:IDPIdera Pharmaceuticals
21/05/200710:20Business WireIdera Pharmaceuticals Announces Chief Financial Officer to Leave Company Effective July 31, 2007AMEX:IDPIdera Pharmaceuticals
15/05/200709:00Business WireIdera Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2007AMEX:IDPIdera Pharmaceuticals
10/05/200709:00Business WireIdera Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare ConferenceAMEX:IDPIdera Pharmaceuticals
03/05/200709:00Business WireIdera Pharmaceuticals to Present at BIO Business Forum and Participate in Toll-Like Receptor Panel at BIO 2007AMEX:IDPIdera Pharmaceuticals
18/04/200710:30Business WireIdera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists atAMEX:IDPIdera Pharmaceuticals
05/04/200709:00Business WireIdera Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals ConferenceAMEX:IDPIdera Pharmaceuticals
06/03/200710:00Business WireIdera Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Financial ResultsAMEX:IDPIdera Pharmaceuticals
06/03/200709:30Business WireIdera Pharmaceuticals Announces Extension of Research Collaboration on Asthma and AllergyAMEX:IDPIdera Pharmaceuticals
22/01/200712:00PR Newswire (US)American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007AMEX:IDPIdera Pharmaceuticals
11/12/200611:00Business WireMerck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera's Toll-like Receptor Agonists in MeAMEX:IDPIdera Pharmaceuticals
30/11/200611:15Business WireIdera Pharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare ConferenceAMEX:IDPIdera Pharmaceuticals
14/11/200611:00Business WireIdera Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2006AMEX:IDPIdera Pharmaceuticals
10/11/200613:35Business WireIdera Presents Preclinical Data on Novel Class of Toll-Like Receptor AntagonistsAMEX:IDPIdera Pharmaceuticals
01/11/200610:15Business WireIdera Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare ConferenceAMEX:IDPIdera Pharmaceuticals
24/10/200609:30Business WireIdera to Draw Down $4 Million under Existing Equity VehicleAMEX:IDPIdera Pharmaceuticals
04/10/200610:25Business WireIdera Pharmaceuticals Announces Issuance of a US Patent for Method of Inducing an Immune Response through Administration of ImmuAMEX:IDPIdera Pharmaceuticals
13/09/200609:30Business WireIdera Pharmaceuticals Announces the Issuance of US Patent Claiming Compounds that Target Toll-like Receptor 9AMEX:IDPIdera Pharmaceuticals
 Apresentando as notícias mais relevantes sobre:AMEX:IDP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
BOBR4
BOMBRIL PN
BOV
VVEO3
CM Hospitalar ON
BOV
IDIV
Dividend
BOV
OIBR3
OI ON
BOV
RENT3
LOCALIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
TELB4
TELEBRAS PN
BOV
TECN3
TECHNOS ON
BOV
PETR4
PETROBRAS PN
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados